Baseline Predictors for Five-Year Visual Acuity Outcomes in the Comparison of AMD Treatment Trials

PURPOSE: To determine baseline predictors of visual acuity (VA) outcomes at 5 years after initiating treatment with ranibizumab or bevacizumab for neovascular age-related macular degeneration (AMD). DESIGN: Secondary analysis of data from a cohort study. PARTICIPANTS: Patients enrolled in the Compar...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Ophthalmol Retina
Autores principales: Ying, Gui-shuang, Maguire, Maureen G., Pan, Wei, Grunwald, Juan E., Daniel, Ebenezer, Jaffe, Glenn J., Toth, Cynthia A, Hagstrom, Stephanie A, Martin, Daniel F.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2018
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6009839/
https://ncbi.nlm.nih.gov/pubmed/29938247
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.oret.2017.10.003
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares